Alamut Visual Plus & interpretación de variantes : Uso ampliado de Alamut en la rutina de laboratorio

Date: June 18, 2026 - June 18, 2026
Type: Live Webinar
Location: EMEA
Areas of Interest: Alamut

June 18 4PM CET / 10AM EST

En este webinar descubrirá como SOPHiA GENETICS facilita el análisis terciario con Alamut™️ Visual Plus simplificando los flujos de trabajo de interpretación de variantes y reduciendo el tiempo de respuesta y resolución de casos complejos. Además, contará con la participación de Yolanda Ramirez García, del Hospital de Donostia, que expondrá al detalle qué funciones de Alamut usan diariamente en la rutina de su laboratorio.

Alamut™ Visual Plus es un navegador genómico integral que se muestra en una interfaz gráfica interactiva, conectando a los usuarios con múltiples fuentes públicas (+60) y herramientas de predicción (splicing & missense). Además, su navegador genómico permite localizar rápidamente sus variantes y la carga y visualización de diferentes tipos de archivos (BAM, Sanger, VCF, BED…). Todo ello con el fin de aumentar la productividad y facilitar la evaluación de la patogenicidad para reducir el tiempo de respuesta del laboratorio. La herramienta se adapta perfectamente a cualquier worklow rutinario, permitiendo ser el único punto de acceso a diferentes bases de datos para las anotaciones de variantes.

Ideal para la rutina de laboratorio, así como para el personal dedicado a investigación, Alamut™️ Visual Plus es la solución definitiva para proporcionar a su laboratorio un análisis de calidad que le brinda mayor tiempo en otras tareas, ya sea para analizar más casos o dedicar esfuerzos a las publicaciones.

Register Now

Name

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Institution(Required)

Job Title(Required)

Area of Interest(Required)

Email(Required)

Phone

Country(Required)

Select US State(Required)

Privacy Policy(Required)

By checking this box, I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. Click here for more information relating to our privacy policy

Marketing Opt-In

I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time.

3rd Party Opt-In

I agree that SOPHiA GENETICS may share my webinar registration details with 3rd parties, and that I may receive marketing communications from these 3rd parties. I understand that I can withdraw my consent at any time.

This field is hidden when viewing the form

Job Title/Industry(Required)

CAPTCHA

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are those of the speakers and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview

SOPHiA DDM™ for Genomics

SOPHiA DDM™ for Radiomics

SOPHiA DDM™ for Multimodal

Professional Services